Browsing: Wegovy
Mars, the snack conglomerate behind M&Ms and Snickers, may have finally satisfied its sweet tooth. The company will acquire Pringles-maker…
Exclusive: The COO of Hims & Hers was the third person to try their GLP-1 drugs—and she’s ready to share her story
Melissa Baird, a health care executive based in Seattle knows first-hand the stigma around weight at work. “I struggled with…
InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. Venture capital funding reached…
Weight Loss Pills Intensify Obesity Drug Race—But Here’s Why Experts Say Injections Aren’t Going Anywhere
Topline Competition in the race to crack the lucrative weight loss drug market is heating up as rivals like Roche,…
InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. Is there a light…
Only 15% of patients prescribed GLP-1s for weight loss were still taking the medications two years later, according to an…
InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. The Federal Trade Commission…
InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. Today, the Colorado Department…
A rare setback as Ozempic-maker Novo Nordisk takes a $820 million hit as its next wonder drug fails
Novo Nordisk A/S said it will take an impairment of about 5.7 billion Danish kroner ($820 million) after halting a…
A whopping 1 in 8 U.S. adults have taken GLP-1 drugs like Wegovy and Ozempic for weight loss and related…